Analyst Bearish on Chesapeake Near-Term and 4 Stock Insights to Watch Now

St. Jude Medical Inc. (NYSE:STJ): According to Bernstein, there is a near-term opportunity in St. Jude given possible PFO closure for stroke data that is being presented at the end of October at TCT, beatable Q3 estimates, and lowered negative headline risk from Riata/Durata. Shares have an Outperform rating.

Don’t Miss: FACEBOOK: The ZUCK Finally Speaks.

Santarus Inc. (NASDAQ:SNTS) target has been raised by Stifel Nicolaus following the company’s successful appeal against Par Pharmaceuticals (NYSE:PRX), along its highly statistically significant Phase III results for Rifamycin SV MMX in traveler’s diarrhea. The firm believes that Santarus’ generic Zegerid will gain an extra $35 million to $45 million in annual sales due to the court decision, and it keeps a Buy rating on the stock.

Chesapeake Energy Corporation (NYSE:CHK): According to Bernstein, Chesapeake’s asset sales continue to be a positive but the company is low on catalysts. The firm suggest that investors use today’s strength as an opportunity to trim positions.

Tangoe Inc (NASDAQ:TNGO): Raymond James hosted an investor field trip to Tangoe and stated that it continues to be committed to its Strong Buy rating because og positive fundamentals. The firm mentions that recent bear stories remain unsubstantiated and the company possesses 20 percent or greater top-line growth.

SPX Corporation (NYSE:SPW): After SPX’s investor day, Stifel Nicolaus thinks that the company’s outlook for margin increases resulting from its facility expansion throughout the next three years is conservative. The firm keeps a Buy rating and an $85 target on the stock.

Don’t Miss: FACEBOOK: The ZUCK Finally Speaks.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>